These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1412207)

  • 21. Monoclonal antibody F1 binds to the kringle domain of factor XII and induces enhanced susceptibility for cleavage by kallikrein.
    Ravon DM; Citarella F; Lubbers YT; Pascucci B; Hack CE
    Blood; 1995 Dec; 86(11):4134-43. PubMed ID: 7492770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis.
    Gallimore MJ; Harris SL; Jones DW; Winter M
    Thromb Res; 2004; 114(2):91-6. PubMed ID: 15306150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells.
    Reddigari SR; Shibayama Y; Brunnée T; Kaplan AP
    J Biol Chem; 1993 Jun; 268(16):11982-7. PubMed ID: 8505323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prekallikrein activator and kallikrein in acetone- and kaolin-activated rat plasma.
    Berstad J
    Acta Pharmacol Toxicol (Copenh); 1979 Sep; 45(3):174-80. PubMed ID: 506739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissemination of contact activation in plasma by plasma kallikrein.
    Cochrane CG; Revak SD
    J Exp Med; 1980 Sep; 152(3):608-19. PubMed ID: 6902742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371).
    Page JD; Colman RW
    J Biol Chem; 1991 May; 266(13):8143-8. PubMed ID: 1708772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of a cationic fragment of high molecular mass kininogen and effect of this fragment on human plasma kallikrein activity.
    Yarovaya GA; Dotsenko VL; Orekhovich VN
    Clin Chim Acta; 1982 Aug; 123(3):261-7. PubMed ID: 6922013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.
    Kaplan AP; Joseph K
    Clin Rev Allergy Immunol; 2016 Oct; 51(2):207-15. PubMed ID: 27273087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor XII does not initiate prekallikrein activation on endothelial cells.
    Røjkjaer R; Hasan AA; Motta G; Schousboe I; Schmaier AH
    Thromb Haemost; 1998 Jul; 80(1):74-81. PubMed ID: 9684789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor XII and prekallikrein-kallikrein-kinin in the cryoactivation of human plasma prorenin.
    Brown CF; Osmond DH
    Clin Sci (Lond); 1984 May; 66(5):533-9. PubMed ID: 6368100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
    Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
    Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of factor XII in human plasma: protection by benzamidine of the cofactor function of high molecular weight kininogen.
    Briseid K; Johansen HT
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):344-52. PubMed ID: 6685967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced or unchanged cofactor function of human high molecular weight kininogen induced by human plasma kallikrein.
    Johansen HT; Briseid K
    Adv Exp Med Biol; 1986; 198 Pt A():147-53. PubMed ID: 3492869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
    Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycated albumin modulates the contact system with implications for the kallikrein-kinin and intrinsic coagulation systems.
    Hardy LJ; Bohinc D; Bane KL; Heal SL; Hethershaw E; Ali M; Palmer-Dench T; Foster R; Longstaff C; Renné T; Stavrou EX; Philippou H
    J Thromb Haemost; 2023 Apr; 21(4):814-827. PubMed ID: 36990522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.
    Mandle RJ; Colman RW; Kaplan AP
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4179-83. PubMed ID: 1069308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel sensitive assay for functional factor XII based on the generation of kallikrein-C1-inhibitor complexes in factor XII-deficient plasma by glass-bound factor XII.
    Dors DM; Nuijens JH; Huijbregts CC; Hack CE
    Thromb Haemost; 1992 Jun; 67(6):644-8. PubMed ID: 1509403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor XII Osaka: abnormal factor XII with partially defective prekallikrein cleavage activity.
    Iijima K; Arakawa Y; Sugahara Y; Matsushita M; Moriguchi Y; Shimohiro H; Nakagawa M
    Thromb Haemost; 2011 Mar; 105(3):473-8. PubMed ID: 21264442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prekallikrein deficiency: the characteristic normalization of the severely prolonged aPTT following increased preincubation time is due to autoactivation of factor XII.
    Asmis LM; Sulzer I; Furlan M; Lämmle B
    Thromb Res; 2002 Mar; 105(6):463-70. PubMed ID: 12091043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protease activity in single-chain prekallikrein.
    Ivanov I; Verhamme IM; Sun MF; Mohammed B; Cheng Q; Matafonov A; Dickeson SK; Joseph K; Kaplan AP; Gailani D
    Blood; 2020 Feb; 135(8):558-567. PubMed ID: 31800958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.